Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults

Fehintola, Fatai A.; Scarsi, Kimberly K.; Qing Ma; Parikh, Sunil; Morse, Gene D.; Taiwo, Babafemi; Akinola, Ibrahim Tope; Adewole, Isaac F.; Lindegardh, Niklas; Phakderaj, Aphiradee; Ojengbede, Oladosu; Murphy, Robert L.; Akinyinka, Olusegun O.; Aweeka, Francesca T.
January 2012
AIDS Research & Treatment;2012, p1
Academic Journal
Background. Nevirapine- (NVP-) based antiretroviral therapy (ART) and artesunate-amodiaquine are frequently coprescribed in areas of HIV and malaria endemicity. We explored the impact of this practice on artesunate and dihydroartemisinin pharmacokinetics. Methods. We conducted a parallel-group pharmacokinetic comparison between HIV-infected patients receiving NVP-based ART (n = 10) and ART-naive controls (n = 11). Artesunate-amodiaquine 200/600 mg was given daily for three days. Measurement of drug concentrations occurred between 0 and 96 hours after the final dose. Pharmacokinetic parameters were determined using noncompartmental analysis. Results. Comparing the NVP group to controls, clearance of artesunate was reduced 50% (1950 versus 2995 L/h; P = 0.03), resulting in a 45% increase in the AUC0-96 (105 versus 69 ug"hr/L; P = 0.02). The half-life of dihydroartemisinin was shorter in the NVP group (1.6 versuss 3.2 h; P = 0.004), but other dihydroartemisinin pharmacokinetic parameters were unchanged. A lower conversion of artesunate to dihydroartemisinin was observed in the NVP group (dihydroartemisinin: artesunate AUC0-96 = 5.6 versuss 8.5 in NVP and control groups, respectively, P = 0.008). Conclusion. Although NVP-containing ART impacted some pharmacokinetic parameters of artesunate and dihydroartemisinin, overall exposure was similar or better in the NVP group.


Related Articles

  • Evaluation of Saliva as an Alternative Matrix for Monitoring Plasma Zidovudine, Lamivudine and Nevirapine Concentrations in Rwanda. Gras, Alain; Schneider, Serge; Karasi, Jean-Claude; Ternes, Anne-Marie; Sauvageot, Nicolas; Karasi-Omes, Christine; Henry, Anne-Pascale; Schmit, Jean-Claude; Seguin-Devaux, Carole; Arendt, Vic // Current HIV Research;Jun2011, Vol. 9 Issue 4, p223 

    Saliva may provide interesting advantages as matrix for compliance measurements, pharmacokinetic studies and therapeutic drug monitoring in resource limited countries. We investigated the feasibility of using saliva for compliance monitoring of zidovudine (ZDV), lamivudine (3TC) and nevirapine...

  • Comparison of Nevirapine Plasma Concentrations between Lead-In and Steady-State Periods in Chinese HIV-Infected Patients. Huijuan Kou; Xiaoli Du; Yanling Li; Jing Xie; Zhifeng Qiu; Min Ye; Qiang Fu; Yang Han; Zhu Zhu; Taisheng Li // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Objectives: To investigate the potential of nevirapine 200 mg once-daily regimen and evaluate the influence of patient characteristics on nevirapine concentrations. Methods: This was a prospective, multicentre cohort study with 532 HIV-infected patients receiving nevirapine as a part of their...

  • Caloric Restriction Alters the Metabolic Response to a Mixed-Meal: Results from a Randomized, Controlled Trial. Huffman, Kim M.; Redman, Leanne M.; Landerman, Lawrence R.; Pieper, Carl F.; Stevens, Robert D.; Muehlbauer, Michael J.; Wenner, Brett R.; Bain, James R.; Kraus, Virginia B.; Newgard, Christopher B.; Ravussin, Eric; Kraus, William E. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Objectives: To determine if caloric restriction (CR) would cause changes in plasma metabolic intermediates in response to a mixed meal, suggestive of changes in the capacity to adapt fuel oxidation to fuel availability or metabolic flexibility, and to determine how any such changes relate to...

  • The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment. Skinner-Adams, Tina S.; Butterworth, Alice S.; Porter, Kimberly A.; D'Amico, Ronald; Sawe, Fred; Shaffer, Doug; Siika, Abraham; Hosseinipour, Mina C.; Stringer, Elizabeth; Currier, Judith S.; Chipato, Tsungai; Salata, Robert; Lockman, Shahin; Eron, Joseph J.; Meshnick, Steven R.; McCarthy, James S. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    HIV protease inhibitors (PIs) show antimalarial activity in vitro and in animals. Whether this translates into a clinical benefit in HIV-infected patients residing in malaria-endemic regions is unknown. We studied the incidence of malaria, as defined by blood smear positivity or a positive...

  • Pharmacokinetics and Pharmacodynamics of Etravirine 400 mg Once Daily in Treatment-Naïve Patients. Di Perri, Giovanni; Green, Bruce; Morrish, Glynn; Hill, Andrew; Faetkenheuer, Gerd; Bickel, Markus; van Delft, Yvon; Kurowski, Michael; Kakuda, Thomas // HIV Clinical Trials;Jul/Aug2013, Vol. 14 Issue 4, p92 

    Background: Etravirine is currently approved for HIV treatment-experienced patients at a dose of 200 mg twice daily. The long terminal elimination half-life of etravirine should support once-daily dosing.Methods: In the double-blind 48-week SENSE trial, 157 antiretroviral treatment-naïve...

  • Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis. Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Amzal, Billy; Sang-a-gad, Pensiriwan; Lertkoonalak, Rittha; Eiamsirikit, Naree; Tansuphasawasdikul, Somboon; Buranawanitchakorn, Yuwadee; Yutthakasemsunt, Naruepon; Mekviwattanawong, Sripetcharat; McIntosh, Kenneth; Lallemant, Marc // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. Few studies have compared...

  • The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment.  // AIDS Research & Therapy;2011, Vol. 8, p41 

    The article reports on a study conducted to assess the efficacy of nevirapine-containing highly active antiretroviral treatment (HAART) when co-administered with rifampicin-containing antituberculosis treatment (ATT). The study also measures plasma nevirapine concentrations in HIV-tuberculosis...

  • Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. Mossdorf, Erik; Stoeckle, Marcel; Mwaigomole, Emmanuel G.; Chiweka, Evarist; Kibatala, Patience L.; Geubbels, Eveline; Urassa, Honoraty; Abdulla, Salim; Elzi, Luigia; Tanner, Marcel; Furrer, Hansjakob; Hatz, Christoph; Battegay, Manuel // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p98 

    Background: Data on combination antiretroviral therapy (cART) in remote rural African regions is increasing. Methods: We assessed prospectively initial cART in HIV-infected adults treated from 2005 to 2008 at St. Francis Designated District Hospital, Ifakara, Tanzania. Adherence was assisted by...

  • Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Scarsi, Kimberly K.; Fehintola, Fatai A.; Ma, Qing; Aweeka, Francesca T.; Darin, Kristin M.; Morse, Gene D.; Akinola, Ibrahim Temitope; Adedeji, Waheed A.; Lindegardh, Niklas; Tarning, Joel; Ojengbede, Oladosu; Adewole, Isaac F.; Taiwo, Babafemi; Murphy, Robert L.; Akinyinka, Olusegun O.; Parikh, Sunil // Journal of Antimicrobial Chemotherapy (JAC);May2014, Vol. 69 Issue 5, p1370 

    Objectives Artesunate plus amodiaquine is used for malaria treatment in regions with overlapping HIV endemicity. Co-administration of artesunate/amodiaquine with antiretroviral therapy (ART) may result in drug–drug interactions, but minimal data exist. This study evaluated the impact of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics